<?xml version="1.0" encoding="ISO-8859-1"?>

<rdf:RDF
 xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
 xmlns="http://purl.org/rss/1.0/"
 xmlns:taxo="http://purl.org/rss/1.0/modules/taxonomy/"
 xmlns:dc="http://purl.org/dc/elements/1.1/"
 xmlns:syn="http://purl.org/rss/1.0/modules/syndication/"
 xmlns:prism="http://purl.org/rss/1.0/modules/prism/"
 xmlns:admin="http://webns.net/mvcb/"
>

<channel rdf:about="http://cpt.sagepub.com/">
<title>J Cardiovasc Pharmacol Ther: Most-Cited Full-Text Articles</title>
<link>http://cpt.sagepub.com/</link>
<description>Most-cited rankings are recalculated at the beginning of the month and are based on citations to articles on this journal site from articles in other HighWire-hosted journals.</description>
<prism:coverDisplayDate>2009-11-07</prism:coverDisplayDate>
<items>
 <rdf:Seq>
  <rdf:li rdf:resource="http://cpt.sagepub.com/cgi/content/short/6/1/5?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://cpt.sagepub.com/cgi/content/short/7/1_suppl/S17?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://cpt.sagepub.com/cgi/content/short/11/1/55?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://cpt.sagepub.com/cgi/content/short/7/1_suppl/S3?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://cpt.sagepub.com/cgi/content/short/6/4/341?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://cpt.sagepub.com/cgi/content/short/8/1_suppl/S5?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://cpt.sagepub.com/cgi/content/short/10/4/225?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://cpt.sagepub.com/cgi/content/short/9/4/227?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://cpt.sagepub.com/cgi/content/short/9/1_suppl/S65?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://cpt.sagepub.com/cgi/content/short/8/4/253?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://cpt.sagepub.com/cgi/content/short/7/3/147?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://cpt.sagepub.com/cgi/content/short/6/4/385?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://cpt.sagepub.com/cgi/content/short/7/1_suppl/S25?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://cpt.sagepub.com/cgi/content/short/8/1_suppl/S13?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://cpt.sagepub.com/cgi/content/short/7/4/247?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://cpt.sagepub.com/cgi/content/short/7/1/1?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://cpt.sagepub.com/cgi/content/short/6/4/313?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://cpt.sagepub.com/cgi/content/short/12/3/205?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://cpt.sagepub.com/cgi/content/short/9/1_suppl/S85?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://cpt.sagepub.com/cgi/content/short/2/1/27?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://cpt.sagepub.com/cgi/content/short/8/1/71?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://cpt.sagepub.com/cgi/content/short/7/4/219?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://cpt.sagepub.com/cgi/content/short/5/1/51?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://cpt.sagepub.com/cgi/content/short/12/2/153?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://cpt.sagepub.com/cgi/content/short/7/1_suppl/S7?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://cpt.sagepub.com/cgi/content/short/1/2/107?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://cpt.sagepub.com/cgi/content/short/3/1/51?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://cpt.sagepub.com/cgi/content/short/9/1/27?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://cpt.sagepub.com/cgi/content/short/7/3/131?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://cpt.sagepub.com/cgi/content/short/6/2/175?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://cpt.sagepub.com/cgi/content/short/7/1_suppl/S21?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://cpt.sagepub.com/cgi/content/short/7/1_suppl/S11?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://cpt.sagepub.com/cgi/content/short/10/4_suppl/S15?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://cpt.sagepub.com/cgi/content/short/1/4/287?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://cpt.sagepub.com/cgi/content/short/2/1/17?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://cpt.sagepub.com/cgi/content/short/2/1/47?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://cpt.sagepub.com/cgi/content/short/2/1/73?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://cpt.sagepub.com/cgi/content/short/4/1/49?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://cpt.sagepub.com/cgi/content/short/9/4/279?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://cpt.sagepub.com/cgi/content/short/8/4/277?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://cpt.sagepub.com/cgi/content/short/8/3/207?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://cpt.sagepub.com/cgi/content/short/8/3/201?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://cpt.sagepub.com/cgi/content/short/8/2/127?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://cpt.sagepub.com/cgi/content/short/8/1/61?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://cpt.sagepub.com/cgi/content/short/7/3/155?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://cpt.sagepub.com/cgi/content/short/7/1/9?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://cpt.sagepub.com/cgi/content/short/6/3/237?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://cpt.sagepub.com/cgi/content/short/6/2/147?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://cpt.sagepub.com/cgi/content/short/6/1/31?rss=1&amp;ssource=mfc" />
  <rdf:li rdf:resource="http://cpt.sagepub.com/cgi/content/short/13/2/130?rss=1&amp;ssource=mfc" />
 </rdf:Seq>
</items>
</channel>

<item rdf:about="http://cpt.sagepub.com/cgi/content/short/6/1/5?rss=1&amp;ssource=mfc">
<title><![CDATA[Arterial Elastance and Wave Reflection Augmentation of Systolic Blood Pressure: Deleterious Effects and Implications for Therapy]]></title>
<link>http://cpt.sagepub.com/cgi/content/short/6/1/5?rss=1&amp;ssource=mfc</link>
<description><![CDATA[Wilmer W. Nichols, David G. Edwards<br />Mar  1, 2001; 6:5-21<br />Article]]></description>
<dc:creator>Wilmer W. Nichols, David G. Edwards</dc:creator>
<dc:date>2001-03-01</dc:date>
<dc:identifier>10.1177/107424840100600102</dc:identifier>
<dc:title><![CDATA[Arterial Elastance and Wave Reflection Augmentation of Systolic Blood Pressure: Deleterious Effects and Implications for Therapy]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://cpt.sagepub.com/cgi/content/short/7/1_suppl/S17?rss=1&amp;ssource=mfc">
<title><![CDATA[Flight Microangiopathy in Medium-to-Long Distance Flights: Prevention of Edema and Microcirculation Alterations with HR (Paroven, Venoruton; 0-({beta}-hydroxyethyl)-rutosides): A Prospective, Randomized, Controlled Trial]]></title>
<link>http://cpt.sagepub.com/cgi/content/short/7/1_suppl/S17?rss=1&amp;ssource=mfc</link>
<description><![CDATA[M. R. Cesarone, G. Belcaro, L. Incandela, G. Geroulakos, M. Griffin, A. Lennox, M. T. DeSanctis, G. Acerbi<br />Mar  1, 2002; 7:17-20<br />Article]]></description>
<dc:creator>M. R. Cesarone, G. Belcaro, L. Incandela, G. Geroulakos, M. Griffin, A. Lennox, M. T. DeSanctis, G. Acerbi</dc:creator>
<dc:date>2002-03-01</dc:date>
<dc:identifier>10.1177/107424840200700105</dc:identifier>
<dc:title><![CDATA[Flight Microangiopathy in Medium-to-Long Distance Flights: Prevention of Edema and Microcirculation Alterations with HR (Paroven, Venoruton; 0-({beta}-hydroxyethyl)-rutosides): A Prospective, Randomized, Controlled Trial]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://cpt.sagepub.com/cgi/content/short/11/1/55?rss=1&amp;ssource=mfc">
<title><![CDATA[Postconditioning Markedly Attenuates Ventricular Arrhythmias After Ischemia-Reperfusion]]></title>
<link>http://cpt.sagepub.com/cgi/content/short/11/1/55?rss=1&amp;ssource=mfc</link>
<description><![CDATA[Robert A. Kloner, Joan Dow, Anil Bhandari<br />Mar  1, 2006; 11:55-63<br />Article]]></description>
<dc:creator>Robert A. Kloner, Joan Dow, Anil Bhandari</dc:creator>
<dc:date>2006-03-01</dc:date>
<dc:identifier>10.1177/107424840601100105</dc:identifier>
<dc:title><![CDATA[Postconditioning Markedly Attenuates Ventricular Arrhythmias After Ischemia-Reperfusion]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://cpt.sagepub.com/cgi/content/short/7/1_suppl/S3?rss=1&amp;ssource=mfc">
<title><![CDATA[Methods of Evaluation and Quantification of Microangiopathy in High Perfusion Microangiopathy (Chronic Venous Insufficiency and Diabetic Microangiopathy)]]></title>
<link>http://cpt.sagepub.com/cgi/content/short/7/1_suppl/S3?rss=1&amp;ssource=mfc</link>
<description><![CDATA[M. T. DeSanctis, M. R. Cesarone, L. Incandela, G. Belcaro, G. Acerbi<br />Mar  1, 2002; 7:3-6<br />Article]]></description>
<dc:creator>M. T. DeSanctis, M. R. Cesarone, L. Incandela, G. Belcaro, G. Acerbi</dc:creator>
<dc:date>2002-03-01</dc:date>
<dc:identifier>10.1177/107424840200700102</dc:identifier>
<dc:title><![CDATA[Methods of Evaluation and Quantification of Microangiopathy in High Perfusion Microangiopathy (Chronic Venous Insufficiency and Diabetic Microangiopathy)]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://cpt.sagepub.com/cgi/content/short/6/4/341?rss=1&amp;ssource=mfc">
<title><![CDATA[Efficacy of Amiodarone for the Termination of Chronic Atrial Fibrillation and Maintenance of Normal Sinus Rhythm: A Prospective, Multicenter, Randomized, Controlled, Double Blind Trial]]></title>
<link>http://cpt.sagepub.com/cgi/content/short/6/4/341?rss=1&amp;ssource=mfc</link>
<description><![CDATA[Jorge Galperin, Marcelo V. Elizari, Pablo A. Chiale, Remberto Torres Molina, Rauil Ledesma, Angel O. Scapin, Manuel Vaizquez Blanco<br />Dec  1, 2001; 6:341-350<br />Article]]></description>
<dc:creator>Jorge Galperin, Marcelo V. Elizari, Pablo A. Chiale, Remberto Torres Molina, Rauil Ledesma, Angel O. Scapin, Manuel Vaizquez Blanco</dc:creator>
<dc:date>2001-12-01</dc:date>
<dc:identifier>10.1177/107424840100600403</dc:identifier>
<dc:title><![CDATA[Efficacy of Amiodarone for the Termination of Chronic Atrial Fibrillation and Maintenance of Normal Sinus Rhythm: A Prospective, Multicenter, Randomized, Controlled, Double Blind Trial]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://cpt.sagepub.com/cgi/content/short/8/1_suppl/S5?rss=1&amp;ssource=mfc">
<title><![CDATA[Atrial Electrophysiology and Mechanisms of Atrial Fibrillation]]></title>
<link>http://cpt.sagepub.com/cgi/content/short/8/1_suppl/S5?rss=1&amp;ssource=mfc</link>
<description><![CDATA[Stanley Nattel<br />Mar  1, 2003; 8:5-11<br />Article]]></description>
<dc:creator>Stanley Nattel</dc:creator>
<dc:date>2003-03-01</dc:date>
<dc:identifier>10.1177/107424840300800102</dc:identifier>
<dc:title><![CDATA[Atrial Electrophysiology and Mechanisms of Atrial Fibrillation]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://cpt.sagepub.com/cgi/content/short/10/4/225?rss=1&amp;ssource=mfc">
<title><![CDATA[Intramyocardial Injection of Allogenic Bone Marrow-Derived Mesenchymal Stem Cells Without Immunosuppression Preserves Cardiac Function in a Porcine Model of Myocardial Infarction]]></title>
<link>http://cpt.sagepub.com/cgi/content/short/10/4/225?rss=1&amp;ssource=mfc</link>
<description><![CDATA[Raj R. Makkar, Matthew J. Price, Michael Lill, Malka Frantzen, Kaname Takizawa, Thomas Kleisli, Jie Zheng, Saibal Kar, Robert McClelan, Takeshi Miyamota, Justin Bick-Forrester, Michael C. Fishbein, Prediman K. Shah, James S. Forrester, Behrooz Sharifi, Peng-Sheng Chen, Mohammed Qayyum<br />Oct  1, 2005; 10:225-233<br />Article]]></description>
<dc:creator>Raj R. Makkar, Matthew J. Price, Michael Lill, Malka Frantzen, Kaname Takizawa, Thomas Kleisli, Jie Zheng, Saibal Kar, Robert McClelan, Takeshi Miyamota, Justin Bick-Forrester, Michael C. Fishbein, Prediman K. Shah, James S. Forrester, Behrooz Sharifi, Peng-Sheng Chen, Mohammed Qayyum</dc:creator>
<dc:date>2005-10-01</dc:date>
<dc:identifier>10.1177/107424840501000403</dc:identifier>
<dc:title><![CDATA[Intramyocardial Injection of Allogenic Bone Marrow-Derived Mesenchymal Stem Cells Without Immunosuppression Preserves Cardiac Function in a Porcine Model of Myocardial Infarction]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://cpt.sagepub.com/cgi/content/short/9/4/227?rss=1&amp;ssource=mfc">
<title><![CDATA[Intravenous Nitroglycerin in the Treatment of Decompensated Heart Failure: Potential Benefits and Limitations]]></title>
<link>http://cpt.sagepub.com/cgi/content/short/9/4/227?rss=1&amp;ssource=mfc</link>
<description><![CDATA[Uri Elkayam, Fahed Bitar, Mohammed W. Akhter, Salman Khan, Saber Patrus, Mahyar Derakhshani<br />Oct  1, 2004; 9:227-241<br />Article]]></description>
<dc:creator>Uri Elkayam, Fahed Bitar, Mohammed W. Akhter, Salman Khan, Saber Patrus, Mahyar Derakhshani</dc:creator>
<dc:date>2004-10-01</dc:date>
<dc:identifier>10.1177/107424840400900403</dc:identifier>
<dc:title><![CDATA[Intravenous Nitroglycerin in the Treatment of Decompensated Heart Failure: Potential Benefits and Limitations]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://cpt.sagepub.com/cgi/content/short/9/1_suppl/S65?rss=1&amp;ssource=mfc">
<title><![CDATA[Electrophysiologic Properties and Antiarrhythmic Actions of a Novel Antianginal Agent]]></title>
<link>http://cpt.sagepub.com/cgi/content/short/9/1_suppl/S65?rss=1&amp;ssource=mfc</link>
<description><![CDATA[Charles Antzelevitch, Luiz Belardinelli, Lin Wu, Heather Fraser, Andrew C. Zygmunt, Alexander Burashnikov, Jose M. Di Diego, Jeffrey M. Fish, Jonathan M. Cordeiro, Robert J. Goodrow Jr, Fabiana Scomik, Guillermo Perez<br />Mar  1, 2004; 9:65-83<br />Article]]></description>
<dc:creator>Charles Antzelevitch, Luiz Belardinelli, Lin Wu, Heather Fraser, Andrew C. Zygmunt, Alexander Burashnikov, Jose M. Di Diego, Jeffrey M. Fish, Jonathan M. Cordeiro, Robert J. Goodrow Jr, Fabiana Scomik, Guillermo Perez</dc:creator>
<dc:date>2004-03-01</dc:date>
<dc:identifier>10.1177/107424840400900106</dc:identifier>
<dc:title><![CDATA[Electrophysiologic Properties and Antiarrhythmic Actions of a Novel Antianginal Agent]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://cpt.sagepub.com/cgi/content/short/8/4/253?rss=1&amp;ssource=mfc">
<title><![CDATA[Atherosclerosis in Type 2 Diabetes Mellitus: The Role of Insulin Resistance]]></title>
<link>http://cpt.sagepub.com/cgi/content/short/8/4/253?rss=1&amp;ssource=mfc</link>
<description><![CDATA[Karol E. Watson, Anne L. Peters Harmel, Gary Matson<br />Dec  1, 2003; 8:253-260<br />Article]]></description>
<dc:creator>Karol E. Watson, Anne L. Peters Harmel, Gary Matson</dc:creator>
<dc:date>2003-12-01</dc:date>
<dc:identifier>10.1177/107424840300800402</dc:identifier>
<dc:title><![CDATA[Atherosclerosis in Type 2 Diabetes Mellitus: The Role of Insulin Resistance]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://cpt.sagepub.com/cgi/content/short/7/3/147?rss=1&amp;ssource=mfc">
<title><![CDATA[Oxidized Low-Density Lipoprotein Receptor LOX-1 and Apoptosis in Human Atherosclerotic Lesions]]></title>
<link>http://cpt.sagepub.com/cgi/content/short/7/3/147?rss=1&amp;ssource=mfc</link>
<description><![CDATA[D. Y. Li, H. J. Chen, E. D. Staples, K. Ozaki, B. Annex, B. K. Singh, R. Vermani, J. L. Mehtat<br />Sep  1, 2002; 7:147-153<br />Article]]></description>
<dc:creator>D. Y. Li, H. J. Chen, E. D. Staples, K. Ozaki, B. Annex, B. K. Singh, R. Vermani, J. L. Mehtat</dc:creator>
<dc:date>2002-09-01</dc:date>
<dc:identifier>10.1177/107424840200700304</dc:identifier>
<dc:title><![CDATA[Oxidized Low-Density Lipoprotein Receptor LOX-1 and Apoptosis in Human Atherosclerotic Lesions]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://cpt.sagepub.com/cgi/content/short/6/4/385?rss=1&amp;ssource=mfc">
<title><![CDATA[Delta Opioid Receptors Inhibit Vagal Bradycardia in the Sinoatrial Node]]></title>
<link>http://cpt.sagepub.com/cgi/content/short/6/4/385?rss=1&amp;ssource=mfc</link>
<description><![CDATA[Keith E. Jackson, Martin Farias, Amber Stanfill, James L. Caffrey<br />Dec  1, 2001; 6:385-393<br />Article]]></description>
<dc:creator>Keith E. Jackson, Martin Farias, Amber Stanfill, James L. Caffrey</dc:creator>
<dc:date>2001-12-01</dc:date>
<dc:identifier>10.1177/107424840100600408</dc:identifier>
<dc:title><![CDATA[Delta Opioid Receptors Inhibit Vagal Bradycardia in the Sinoatrial Node]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://cpt.sagepub.com/cgi/content/short/7/1_suppl/S25?rss=1&amp;ssource=mfc">
<title><![CDATA[Variations in Plasma Free Radicals in Patients with Venous Hypertension with HR (Paroven, Venoruton; 0-({beta}-hydroxyethyl)-rutosides): A Clinical, Prospective, Placebo-Controlled, Randomized Trial]]></title>
<link>http://cpt.sagepub.com/cgi/content/short/7/1_suppl/S25?rss=1&amp;ssource=mfc</link>
<description><![CDATA[M. R. Cesarone, L. Incandela, M. T. DeSanctis, G. Belcaro, M. Dugall, G. Acerbi<br />Mar  1, 2002; 7:25-28<br />Article]]></description>
<dc:creator>M. R. Cesarone, L. Incandela, M. T. DeSanctis, G. Belcaro, M. Dugall, G. Acerbi</dc:creator>
<dc:date>2002-03-01</dc:date>
<dc:identifier>10.1177/107424840200700107</dc:identifier>
<dc:title><![CDATA[Variations in Plasma Free Radicals in Patients with Venous Hypertension with HR (Paroven, Venoruton; 0-({beta}-hydroxyethyl)-rutosides): A Clinical, Prospective, Placebo-Controlled, Randomized Trial]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://cpt.sagepub.com/cgi/content/short/8/1_suppl/S13?rss=1&amp;ssource=mfc">
<title><![CDATA[Atrial Fibrillation: Epidemiologic Considerations and Rationale for Conversion and Maintenance of Sinus Rhythm]]></title>
<link>http://cpt.sagepub.com/cgi/content/short/8/1_suppl/S13?rss=1&amp;ssource=mfc</link>
<description><![CDATA[Bramah N. Singh<br />Mar  1, 2003; 8:13-26<br />Article]]></description>
<dc:creator>Bramah N. Singh</dc:creator>
<dc:date>2003-03-01</dc:date>
<dc:identifier>10.1177/107424840300800103</dc:identifier>
<dc:title><![CDATA[Atrial Fibrillation: Epidemiologic Considerations and Rationale for Conversion and Maintenance of Sinus Rhythm]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://cpt.sagepub.com/cgi/content/short/7/4/247?rss=1&amp;ssource=mfc">
<title><![CDATA[Anti-thrombotic Effects of Atorvastatin-An Effect Unrelated to Lipid Lowering]]></title>
<link>http://cpt.sagepub.com/cgi/content/short/7/4/247?rss=1&amp;ssource=mfc</link>
<description><![CDATA[V. Gaddam, D. Y. Li, J. L. Mehta<br />Dec  1, 2002; 7:247-253<br />Article]]></description>
<dc:creator>V. Gaddam, D. Y. Li, J. L. Mehta</dc:creator>
<dc:date>2002-12-01</dc:date>
<dc:identifier>10.1177/107424840200700408</dc:identifier>
<dc:title><![CDATA[Anti-thrombotic Effects of Atorvastatin-An Effect Unrelated to Lipid Lowering]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://cpt.sagepub.com/cgi/content/short/7/1/1?rss=1&amp;ssource=mfc">
<title><![CDATA[Peroxisome Proliferator-Activated Receptor Ligands as Antiatherogenic Agents: Panacea or Another Pandora's Box?]]></title>
<link>http://cpt.sagepub.com/cgi/content/short/7/1/1?rss=1&amp;ssource=mfc</link>
<description><![CDATA[Behzad Molavi, Neda Rasouli, Jawahar L. Mehta<br />Mar  1, 2002; 7:1-8<br />Article]]></description>
<dc:creator>Behzad Molavi, Neda Rasouli, Jawahar L. Mehta</dc:creator>
<dc:date>2002-03-01</dc:date>
<dc:identifier>10.1177/107424840200700i101</dc:identifier>
<dc:title><![CDATA[Peroxisome Proliferator-Activated Receptor Ligands as Antiatherogenic Agents: Panacea or Another Pandora's Box?]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://cpt.sagepub.com/cgi/content/short/6/4/313?rss=1&amp;ssource=mfc">
<title><![CDATA[Morbidity and Mortality in Cardiovascular Disorders: Impact of Reduced Heart Rate]]></title>
<link>http://cpt.sagepub.com/cgi/content/short/6/4/313?rss=1&amp;ssource=mfc</link>
<description><![CDATA[Bramah N. Singh<br />Dec  1, 2001; 6:313-331<br />Article]]></description>
<dc:creator>Bramah N. Singh</dc:creator>
<dc:date>2001-12-01</dc:date>
<dc:identifier>10.1177/107424840100600401</dc:identifier>
<dc:title><![CDATA[Morbidity and Mortality in Cardiovascular Disorders: Impact of Reduced Heart Rate]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://cpt.sagepub.com/cgi/content/short/12/3/205?rss=1&amp;ssource=mfc">
<title><![CDATA[Greater Inhibition of Platelet Aggregation and Reduced Response Variability With Prasugrel Versus Clopidogrel: An Integrated Analysis]]></title>
<link>http://cpt.sagepub.com/cgi/content/short/12/3/205?rss=1&amp;ssource=mfc</link>
<description><![CDATA[Govinda J. Weerakkody, Joseph A. Jakubowski, John T. Brandt, Christopher D. Payne, Hideo Naganuma, Kenneth J. Winters<br />Sep  1, 2007; 12:205-212<br />Article]]></description>
<dc:creator>Govinda J. Weerakkody, Joseph A. Jakubowski, John T. Brandt, Christopher D. Payne, Hideo Naganuma, Kenneth J. Winters</dc:creator>
<dc:date>2007-09-01</dc:date>
<dc:identifier>10.1177/1074248407304731</dc:identifier>
<dc:title><![CDATA[Greater Inhibition of Platelet Aggregation and Reduced Response Variability With Prasugrel Versus Clopidogrel: An Integrated Analysis]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://cpt.sagepub.com/cgi/content/short/9/1_suppl/S85?rss=1&amp;ssource=mfc">
<title><![CDATA[Antiarrhythmic and Proarrhythmic Properties of QT-Prolonging Antianginal Drugs]]></title>
<link>http://cpt.sagepub.com/cgi/content/short/9/1_suppl/S85?rss=1&amp;ssource=mfc</link>
<description><![CDATA[Bramah N. Singh, Nitin Wadhani<br />Mar  1, 2004; 9:85-97<br />Article]]></description>
<dc:creator>Bramah N. Singh, Nitin Wadhani</dc:creator>
<dc:date>2004-03-01</dc:date>
<dc:identifier>10.1177/107424840400900107</dc:identifier>
<dc:title><![CDATA[Antiarrhythmic and Proarrhythmic Properties of QT-Prolonging Antianginal Drugs]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://cpt.sagepub.com/cgi/content/short/2/1/27?rss=1&amp;ssource=mfc">
<title><![CDATA[d-Sotalol Induces Marked Action Potential Prolongation and Early Afterdepolarizations in M but Not Epicardial or Endocardial Cells of the Canine Ventricle]]></title>
<link>http://cpt.sagepub.com/cgi/content/short/2/1/27?rss=1&amp;ssource=mfc</link>
<description><![CDATA[Serge Sicouri, Sandra Moro, Marcelo V. Elizari<br />Jan  1, 1997; 2:27-37<br />Article]]></description>
<dc:creator>Serge Sicouri, Sandra Moro, Marcelo V. Elizari</dc:creator>
<dc:date>1997-01-01</dc:date>
<dc:identifier>10.1177/107424849700200104</dc:identifier>
<dc:title><![CDATA[d-Sotalol Induces Marked Action Potential Prolongation and Early Afterdepolarizations in M but Not Epicardial or Endocardial Cells of the Canine Ventricle]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://cpt.sagepub.com/cgi/content/short/8/1/71?rss=1&amp;ssource=mfc">
<title><![CDATA[Cardiovascular Pharmacogenomics: Current Status, Future Prospects]]></title>
<link>http://cpt.sagepub.com/cgi/content/short/8/1/71?rss=1&amp;ssource=mfc</link>
<description><![CDATA[Jeffrey L. Anderson, John F. Carlquist, Benjamin D. Home, Joseph B. Muhlestein<br />Mar  1, 2003; 8:71-83<br />Article]]></description>
<dc:creator>Jeffrey L. Anderson, John F. Carlquist, Benjamin D. Home, Joseph B. Muhlestein</dc:creator>
<dc:date>2003-03-01</dc:date>
<dc:identifier>10.1177/107424840300800i110</dc:identifier>
<dc:title><![CDATA[Cardiovascular Pharmacogenomics: Current Status, Future Prospects]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://cpt.sagepub.com/cgi/content/short/7/4/219?rss=1&amp;ssource=mfc">
<title><![CDATA[Effect of Ciprofibrate on Lipoproteins, Fibrinogen, Renal Function, and Hepatic Enzymes]]></title>
<link>http://cpt.sagepub.com/cgi/content/short/7/4/219?rss=1&amp;ssource=mfc</link>
<description><![CDATA[Evangelos Rizos, Eleni Bairaktari, Emmanouel Ganotakis, Vasilios Tsimihodimos, Dimitri P. Mikhailidis, Moses Elisaf<br />Dec  1, 2002; 7:219-226<br />Article]]></description>
<dc:creator>Evangelos Rizos, Eleni Bairaktari, Emmanouel Ganotakis, Vasilios Tsimihodimos, Dimitri P. Mikhailidis, Moses Elisaf</dc:creator>
<dc:date>2002-12-01</dc:date>
<dc:identifier>10.1177/107424840200700404</dc:identifier>
<dc:title><![CDATA[Effect of Ciprofibrate on Lipoproteins, Fibrinogen, Renal Function, and Hepatic Enzymes]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://cpt.sagepub.com/cgi/content/short/5/1/51?rss=1&amp;ssource=mfc">
<title><![CDATA[Beneficial Effects of Vitamin E Treatment in Acute Myocardial Infarction]]></title>
<link>http://cpt.sagepub.com/cgi/content/short/5/1/51?rss=1&amp;ssource=mfc</link>
<description><![CDATA[Rajat Sethi, Nobuakira Takeda, Makoto Nagano, Naranjan S. Dhalla<br />Jan  1, 2000; 5:51-58<br />Article]]></description>
<dc:creator>Rajat Sethi, Nobuakira Takeda, Makoto Nagano, Naranjan S. Dhalla</dc:creator>
<dc:date>2000-01-01</dc:date>
<dc:identifier>10.1177/107424840000500107</dc:identifier>
<dc:title><![CDATA[Beneficial Effects of Vitamin E Treatment in Acute Myocardial Infarction]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://cpt.sagepub.com/cgi/content/short/12/2/153?rss=1&amp;ssource=mfc">
<title><![CDATA[Postconditioning Does Not Reduce Myocardial Infarct Size in an In Vivo Regional Ischemia Rodent Model]]></title>
<link>http://cpt.sagepub.com/cgi/content/short/12/2/153?rss=1&amp;ssource=mfc</link>
<description><![CDATA[Joan Dow, Robert A. Kloner<br />Jun  1, 2007; 12:153-163<br />Article]]></description>
<dc:creator>Joan Dow, Robert A. Kloner</dc:creator>
<dc:date>2007-06-01</dc:date>
<dc:identifier>10.1177/1074248407300897</dc:identifier>
<dc:title><![CDATA[Postconditioning Does Not Reduce Myocardial Infarct Size in an In Vivo Regional Ischemia Rodent Model]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://cpt.sagepub.com/cgi/content/short/7/1_suppl/S7?rss=1&amp;ssource=mfc">
<title><![CDATA[HR (Paroven, Venoruton; 0-({beta}-hydroxyethyl)-rutosides) in Venous Hypertensive Microangiopathy: A Prospective, Placebo-Controlled, Randomized Trial]]></title>
<link>http://cpt.sagepub.com/cgi/content/short/7/1_suppl/S7?rss=1&amp;ssource=mfc</link>
<description><![CDATA[L. Incandela, G. Belcaro, S. Renton, M. T. DeSanctis, M. R. Cesarone, P. Bavera, E. Ippolito, M. Bucci, M. Griffin, G. Geroulakos, M. Dugall, G. Golden, G. Acerbi<br />Mar  1, 2002; 7:7-10<br />Article]]></description>
<dc:creator>L. Incandela, G. Belcaro, S. Renton, M. T. DeSanctis, M. R. Cesarone, P. Bavera, E. Ippolito, M. Bucci, M. Griffin, G. Geroulakos, M. Dugall, G. Golden, G. Acerbi</dc:creator>
<dc:date>2002-03-01</dc:date>
<dc:identifier>10.1177/107424840200700103</dc:identifier>
<dc:title><![CDATA[HR (Paroven, Venoruton; 0-({beta}-hydroxyethyl)-rutosides) in Venous Hypertensive Microangiopathy: A Prospective, Placebo-Controlled, Randomized Trial]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://cpt.sagepub.com/cgi/content/short/1/2/107?rss=1&amp;ssource=mfc">
<title><![CDATA[Efficacy and Tolerability of Low-dose Simvastatin and Niacin, Alone and in Combination, in Patients With Combined Hyperlipidemia: A Prospective Trial]]></title>
<link>http://cpt.sagepub.com/cgi/content/short/1/2/107?rss=1&amp;ssource=mfc</link>
<description><![CDATA[Evan A. Stein, Michael H. Davidson, Carlos A. Dujovne, Donald B. Hunninghake, Ronald B. Goldberg, D. Roger Illingworth, Robert H. Knopp, Valery T. Miller, Philip Frost, Jonathan L. Isaacsohn, Yale B. Mitchel, Michael R. Melino, Deborah Shapiro, Jonathan A. Tobert<br />Apr  1, 1996; 1:107-116<br />]]></description>
<dc:creator>Evan A. Stein, Michael H. Davidson, Carlos A. Dujovne, Donald B. Hunninghake, Ronald B. Goldberg, D. Roger Illingworth, Robert H. Knopp, Valery T. Miller, Philip Frost, Jonathan L. Isaacsohn, Yale B. Mitchel, Michael R. Melino, Deborah Shapiro, Jonathan A. Tobert</dc:creator>
<dc:date>1996-04-01</dc:date>
<dc:identifier>10.1177/107424849600100204</dc:identifier>
<dc:title><![CDATA[Efficacy and Tolerability of Low-dose Simvastatin and Niacin, Alone and in Combination, in Patients With Combined Hyperlipidemia: A Prospective Trial]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://cpt.sagepub.com/cgi/content/short/3/1/51?rss=1&amp;ssource=mfc">
<title><![CDATA[Formation of Reactive Oxygen Species in Various Vascular Cells During Glyceryltrinitrate Metabolism]]></title>
<link>http://cpt.sagepub.com/cgi/content/short/3/1/51?rss=1&amp;ssource=mfc</link>
<description><![CDATA[S. Dikalov, B. Fink, M. Skatchkov, O. Sommer, E. Bassenge<br />Jan  1, 1998; 3:51-61<br />Article]]></description>
<dc:creator>S. Dikalov, B. Fink, M. Skatchkov, O. Sommer, E. Bassenge</dc:creator>
<dc:date>1998-01-01</dc:date>
<dc:identifier>10.1177/107424849800300107</dc:identifier>
<dc:title><![CDATA[Formation of Reactive Oxygen Species in Various Vascular Cells During Glyceryltrinitrate Metabolism]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://cpt.sagepub.com/cgi/content/short/9/1/27?rss=1&amp;ssource=mfc">
<title><![CDATA[Effect of Fenofibrate on Serum Inflammatory Markers in Patients With High Triglyceride Values]]></title>
<link>http://cpt.sagepub.com/cgi/content/short/9/1/27?rss=1&amp;ssource=mfc</link>
<description><![CDATA[Vasilis Tsimihodimos, Angeliki Kostoula, Anna Kakafika, Eleni Bairaktari, Alexandros D. Tselepis, Dimitri P. Mikhailidis, Moses Elisaf<br />Mar  1, 2004; 9:27-33<br />Article]]></description>
<dc:creator>Vasilis Tsimihodimos, Angeliki Kostoula, Anna Kakafika, Eleni Bairaktari, Alexandros D. Tselepis, Dimitri P. Mikhailidis, Moses Elisaf</dc:creator>
<dc:date>2004-03-01</dc:date>
<dc:identifier>10.1177/107424840400900i105</dc:identifier>
<dc:title><![CDATA[Effect of Fenofibrate on Serum Inflammatory Markers in Patients With High Triglyceride Values]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://cpt.sagepub.com/cgi/content/short/7/3/131?rss=1&amp;ssource=mfc">
<title><![CDATA[Atrial Fibrillation Following Investigation of Rhythm Management: AFFIRM Trial Outcomes. What Might Be Their Implications for Arrhythmia Control?]]></title>
<link>http://cpt.sagepub.com/cgi/content/short/7/3/131?rss=1&amp;ssource=mfc</link>
<description><![CDATA[Bramah N. Singh<br />Sep  1, 2002; 7:131-133<br />Article]]></description>
<dc:creator>Bramah N. Singh</dc:creator>
<dc:date>2002-09-01</dc:date>
<dc:identifier>10.1177/107424840200700301</dc:identifier>
<dc:title><![CDATA[Atrial Fibrillation Following Investigation of Rhythm Management: AFFIRM Trial Outcomes. What Might Be Their Implications for Arrhythmia Control?]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://cpt.sagepub.com/cgi/content/short/6/2/175?rss=1&amp;ssource=mfc">
<title><![CDATA[Comparative Effects of ACE Inhibitors and an Angiotensin Receptor Blocker on Atherosclerosis and Vascular Function]]></title>
<link>http://cpt.sagepub.com/cgi/content/short/6/2/175?rss=1&amp;ssource=mfc</link>
<description><![CDATA[Yi-ping Sun, Bo-qing Zhu, Amanda E. M. Browne, Satyavardhan Pulukurthy, Tony M. Chou, Krishnankutty Sudhir, Stanton A. Glantz, Prakash C. Deedwania, Kanu Chatterjee, William W. Parmley<br />Jun  1, 2001; 6:175-181<br />Article]]></description>
<dc:creator>Yi-ping Sun, Bo-qing Zhu, Amanda E. M. Browne, Satyavardhan Pulukurthy, Tony M. Chou, Krishnankutty Sudhir, Stanton A. Glantz, Prakash C. Deedwania, Kanu Chatterjee, William W. Parmley</dc:creator>
<dc:date>2001-06-01</dc:date>
<dc:identifier>10.1177/107424840100600209</dc:identifier>
<dc:title><![CDATA[Comparative Effects of ACE Inhibitors and an Angiotensin Receptor Blocker on Atherosclerosis and Vascular Function]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://cpt.sagepub.com/cgi/content/short/7/1_suppl/S21?rss=1&amp;ssource=mfc">
<title><![CDATA[Treatment of Edema and Increased Capillary Filtration in Venous Hypertension with HR (Paroven, Venoruton; 0-({beta}-hydroxyethyl)-rutosides): A Clinical, Prospective, Placebo-Controlled, Randomized, Dose-Ranging Trial]]></title>
<link>http://cpt.sagepub.com/cgi/content/short/7/1_suppl/S21?rss=1&amp;ssource=mfc</link>
<description><![CDATA[M. R. Cesarone, L. Incandela, M. T. DeSanctis, G. Belcaro, M. Griffin, E. Ippolito, G. Acerbi<br />Mar  1, 2002; 7:21-24<br />Article]]></description>
<dc:creator>M. R. Cesarone, L. Incandela, M. T. DeSanctis, G. Belcaro, M. Griffin, E. Ippolito, G. Acerbi</dc:creator>
<dc:date>2002-03-01</dc:date>
<dc:identifier>10.1177/107424840200700106</dc:identifier>
<dc:title><![CDATA[Treatment of Edema and Increased Capillary Filtration in Venous Hypertension with HR (Paroven, Venoruton; 0-({beta}-hydroxyethyl)-rutosides): A Clinical, Prospective, Placebo-Controlled, Randomized, Dose-Ranging Trial]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://cpt.sagepub.com/cgi/content/short/7/1_suppl/S11?rss=1&amp;ssource=mfc">
<title><![CDATA[Treatment of Diabetic Microangiopathy and Edema with HR (Paroven, Venoruton; 0-({beta}-hydroxyethyl)-rutosides): A Prospective, Placebo-Controlled, Randomized Study]]></title>
<link>http://cpt.sagepub.com/cgi/content/short/7/1_suppl/S11?rss=1&amp;ssource=mfc</link>
<description><![CDATA[L. Incandela, M. R. Cesarone, M. T. DeSanctis, G. Belcaro, M. Dugall, G. Acerbi<br />Mar  1, 2002; 7:11-15<br />Article]]></description>
<dc:creator>L. Incandela, M. R. Cesarone, M. T. DeSanctis, G. Belcaro, M. Dugall, G. Acerbi</dc:creator>
<dc:date>2002-03-01</dc:date>
<dc:identifier>10.1177/107424840200700104</dc:identifier>
<dc:title><![CDATA[Treatment of Diabetic Microangiopathy and Edema with HR (Paroven, Venoruton; 0-({beta}-hydroxyethyl)-rutosides): A Prospective, Placebo-Controlled, Randomized Study]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://cpt.sagepub.com/cgi/content/short/10/4_suppl/S15?rss=1&amp;ssource=mfc">
<title><![CDATA[Antiarrhythmic Action of{beta}-Blockers: Potential Mechanisms]]></title>
<link>http://cpt.sagepub.com/cgi/content/short/10/4_suppl/S15?rss=1&amp;ssource=mfc</link>
<description><![CDATA[Paul Dorian<br />Oct  1, 2005; 10:15-22<br />Article]]></description>
<dc:creator>Paul Dorian</dc:creator>
<dc:date>2005-10-01</dc:date>
<dc:identifier>10.1177/10742484050100i403</dc:identifier>
<dc:title><![CDATA[Antiarrhythmic Action of{beta}-Blockers: Potential Mechanisms]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://cpt.sagepub.com/cgi/content/short/1/4/287?rss=1&amp;ssource=mfc">
<title><![CDATA[Differential Electrophysiologic Effects of Chronically Administered         Amiodarone on Canine Purkinje Fibers versus Ventricular Muscle]]></title>
<link>http://cpt.sagepub.com/cgi/content/short/1/4/287?rss=1&amp;ssource=mfc</link>
<description><![CDATA[Julius Gy. Papp, Mikos Nemeth, Iren Krassoi, Lajos Mester, Otto Hala, Andras Varro<br />Oct  1, 1996; 1:287-296<br />]]></description>
<dc:creator>Julius Gy. Papp, Mikos Nemeth, Iren Krassoi, Lajos Mester, Otto Hala, Andras Varro</dc:creator>
<dc:date>1996-10-01</dc:date>
<dc:identifier>10.1177/107424849600100404</dc:identifier>
<dc:title><![CDATA[Differential Electrophysiologic Effects of Chronically Administered         Amiodarone on Canine Purkinje Fibers versus Ventricular Muscle]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://cpt.sagepub.com/cgi/content/short/2/1/17?rss=1&amp;ssource=mfc">
<title><![CDATA[Long-term Treatment With Pravastatin Alone and in Combination With Gemfibrozil in Familial Type IIB Hyperlipoproteinemia or Combined Hyperlipidemia]]></title>
<link>http://cpt.sagepub.com/cgi/content/short/2/1/17?rss=1&amp;ssource=mfc</link>
<description><![CDATA[Claudio Napoli, Stefano Lepore, Paola Chiariello, Mario Condorelli, Massimo Chiariello<br />Jan  1, 1997; 2:17-26<br />Article]]></description>
<dc:creator>Claudio Napoli, Stefano Lepore, Paola Chiariello, Mario Condorelli, Massimo Chiariello</dc:creator>
<dc:date>1997-01-01</dc:date>
<dc:identifier>10.1177/107424849700200103</dc:identifier>
<dc:title><![CDATA[Long-term Treatment With Pravastatin Alone and in Combination With Gemfibrozil in Familial Type IIB Hyperlipoproteinemia or Combined Hyperlipidemia]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://cpt.sagepub.com/cgi/content/short/2/1/47?rss=1&amp;ssource=mfc">
<title><![CDATA[Estradiol, Administered Acutely, Protects Ischemic Myocardium in Both Female and Male Rabbits]]></title>
<link>http://cpt.sagepub.com/cgi/content/short/2/1/47?rss=1&amp;ssource=mfc</link>
<description><![CDATA[Sharon L. Hale, Yochai Birnbaum, Robert A. Kloner<br />Jan  1, 1997; 2:47-52<br />Article]]></description>
<dc:creator>Sharon L. Hale, Yochai Birnbaum, Robert A. Kloner</dc:creator>
<dc:date>1997-01-01</dc:date>
<dc:identifier>10.1177/107424849700200106</dc:identifier>
<dc:title><![CDATA[Estradiol, Administered Acutely, Protects Ischemic Myocardium in Both Female and Male Rabbits]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://cpt.sagepub.com/cgi/content/short/2/1/73?rss=1&amp;ssource=mfc">
<title><![CDATA[The M Cell]]></title>
<link>http://cpt.sagepub.com/cgi/content/short/2/1/73?rss=1&amp;ssource=mfc</link>
<description><![CDATA[Charles Antzelevitch<br />Jan  1, 1997; 2:73-76<br />Article]]></description>
<dc:creator>Charles Antzelevitch</dc:creator>
<dc:date>1997-01-01</dc:date>
<dc:identifier>10.1177/107424849700200109</dc:identifier>
<dc:title><![CDATA[The M Cell]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://cpt.sagepub.com/cgi/content/short/4/1/49?rss=1&amp;ssource=mfc">
<title><![CDATA[Review : Sotalol: Current Status and Expanding Indications]]></title>
<link>http://cpt.sagepub.com/cgi/content/short/4/1/49?rss=1&amp;ssource=mfc</link>
<description><![CDATA[Bramah N. Singh<br />Jan  1, 1999; 4:49-65<br />Article]]></description>
<dc:creator>Bramah N. Singh</dc:creator>
<dc:date>1999-01-01</dc:date>
<dc:identifier>10.1177/107424849900400108</dc:identifier>
<dc:title><![CDATA[Review : Sotalol: Current Status and Expanding Indications]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://cpt.sagepub.com/cgi/content/short/9/4/279?rss=1&amp;ssource=mfc">
<title><![CDATA[Monocyte Chemoattractant Protein 1-Induced Monocyte Infiltration Produces Angiogenesis but Not Arteriogenesis in Chronically Infarcted Myocardium]]></title>
<link>http://cpt.sagepub.com/cgi/content/short/9/4/279?rss=1&amp;ssource=mfc</link>
<description><![CDATA[Ernst R. Schwarz, Dennis A. Meven, Nasir Z. Sulemanjee, Philipp H. Kersting, Tanja Tussing, Erik C. Skobel, Peter Hanrath, Barry F. Uretsky<br />Oct  1, 2004; 9:279-289<br />Article]]></description>
<dc:creator>Ernst R. Schwarz, Dennis A. Meven, Nasir Z. Sulemanjee, Philipp H. Kersting, Tanja Tussing, Erik C. Skobel, Peter Hanrath, Barry F. Uretsky</dc:creator>
<dc:date>2004-10-01</dc:date>
<dc:identifier>10.1177/107424840400900408</dc:identifier>
<dc:title><![CDATA[Monocyte Chemoattractant Protein 1-Induced Monocyte Infiltration Produces Angiogenesis but Not Arteriogenesis in Chronically Infarcted Myocardium]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://cpt.sagepub.com/cgi/content/short/8/4/277?rss=1&amp;ssource=mfc">
<title><![CDATA[Effects of Acetaminophen on Myocardial Infarct Size in Rats]]></title>
<link>http://cpt.sagepub.com/cgi/content/short/8/4/277?rss=1&amp;ssource=mfc</link>
<description><![CDATA[Wangde Dai, Robert A. Kloner<br />Dec  1, 2003; 8:277-284<br />Article]]></description>
<dc:creator>Wangde Dai, Robert A. Kloner</dc:creator>
<dc:date>2003-12-01</dc:date>
<dc:identifier>10.1177/107424840300800405</dc:identifier>
<dc:title><![CDATA[Effects of Acetaminophen on Myocardial Infarct Size in Rats]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://cpt.sagepub.com/cgi/content/short/8/3/207?rss=1&amp;ssource=mfc">
<title><![CDATA[Cardioprotection by Carvedilol: Antiapoptosis is Independent of {beta}-Adrenoceptor Blockage in the Rat Heart]]></title>
<link>http://cpt.sagepub.com/cgi/content/short/8/3/207?rss=1&amp;ssource=mfc</link>
<description><![CDATA[Ernst R. Schwarz, Philipp H. Kersting, Thorsten Reffelmann, Dennis A. Meven, Raja Al-Dashti, Erik C. Skobel, Bernd Klosterhalfen, Peter Hanrath<br />Sep  1, 2003; 8:207-215<br />Article]]></description>
<dc:creator>Ernst R. Schwarz, Philipp H. Kersting, Thorsten Reffelmann, Dennis A. Meven, Raja Al-Dashti, Erik C. Skobel, Bernd Klosterhalfen, Peter Hanrath</dc:creator>
<dc:date>2003-09-01</dc:date>
<dc:identifier>10.1177/107424840300800306</dc:identifier>
<dc:title><![CDATA[Cardioprotection by Carvedilol: Antiapoptosis is Independent of {beta}-Adrenoceptor Blockage in the Rat Heart]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://cpt.sagepub.com/cgi/content/short/8/3/201?rss=1&amp;ssource=mfc">
<title><![CDATA[Anti-inflammatory Effects of Statins in Patients with Aortic Stenosis]]></title>
<link>http://cpt.sagepub.com/cgi/content/short/8/3/201?rss=1&amp;ssource=mfc</link>
<description><![CDATA[Gordon E. Pate, M. Naeem Tahir, Ross T. Murphy, J. Brendan Foley<br />Sep  1, 2003; 8:201-206<br />Article]]></description>
<dc:creator>Gordon E. Pate, M. Naeem Tahir, Ross T. Murphy, J. Brendan Foley</dc:creator>
<dc:date>2003-09-01</dc:date>
<dc:identifier>10.1177/107424840300800305</dc:identifier>
<dc:title><![CDATA[Anti-inflammatory Effects of Statins in Patients with Aortic Stenosis]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://cpt.sagepub.com/cgi/content/short/8/2/127?rss=1&amp;ssource=mfc">
<title><![CDATA[The Combination of Nebivolol plus Pravastatin is Associated with a More Beneficial Metabolic Profile Compared to that of Atenolol plus Pravastatin in Hypertensive Patients with Dyslipidemia: A Pilot Study]]></title>
<link>http://cpt.sagepub.com/cgi/content/short/8/2/127?rss=1&amp;ssource=mfc</link>
<description><![CDATA[Evangelos Rizos, Eleni Bairaktari, Angeliki Kostoula, George Hasiotis, Apostolos Achimastos, Emanuel Ganotakis, Moses Elisaf, D. P. Mikhailidis<br />Jun  1, 2003; 8:127-134<br />Article]]></description>
<dc:creator>Evangelos Rizos, Eleni Bairaktari, Angeliki Kostoula, George Hasiotis, Apostolos Achimastos, Emanuel Ganotakis, Moses Elisaf, D. P. Mikhailidis</dc:creator>
<dc:date>2003-06-01</dc:date>
<dc:identifier>10.1177/107424840300800206</dc:identifier>
<dc:title><![CDATA[The Combination of Nebivolol plus Pravastatin is Associated with a More Beneficial Metabolic Profile Compared to that of Atenolol plus Pravastatin in Hypertensive Patients with Dyslipidemia: A Pilot Study]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://cpt.sagepub.com/cgi/content/short/8/1/61?rss=1&amp;ssource=mfc">
<title><![CDATA[Suppression of Oxidative Stress as a Mechanism of Reduction of Hypercholesterolemic Atherosclerosis by Aspirin]]></title>
<link>http://cpt.sagepub.com/cgi/content/short/8/1/61?rss=1&amp;ssource=mfc</link>
<description><![CDATA[Kailash Prasad, Paul Lee<br />Mar  1, 2003; 8:61-69<br />Article]]></description>
<dc:creator>Kailash Prasad, Paul Lee</dc:creator>
<dc:date>2003-03-01</dc:date>
<dc:identifier>10.1177/107424840300800i109</dc:identifier>
<dc:title><![CDATA[Suppression of Oxidative Stress as a Mechanism of Reduction of Hypercholesterolemic Atherosclerosis by Aspirin]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://cpt.sagepub.com/cgi/content/short/7/3/155?rss=1&amp;ssource=mfc">
<title><![CDATA[Comparison of Verapamil and Ibutilide for the Suppression of Immediate Recurrences of Atrial Fibrillation after Transthoracic Cardioversion]]></title>
<link>http://cpt.sagepub.com/cgi/content/short/7/3/155?rss=1&amp;ssource=mfc</link>
<description><![CDATA[Christian Sticherling, Mehmet Ozaydin, Hiroshi Tada, Hakan Oral, Frank Pelosi, Bradley P. Knight, S. Adam Strickberger, Fred Morady<br />Sep  1, 2002; 7:155-160<br />Article]]></description>
<dc:creator>Christian Sticherling, Mehmet Ozaydin, Hiroshi Tada, Hakan Oral, Frank Pelosi, Bradley P. Knight, S. Adam Strickberger, Fred Morady</dc:creator>
<dc:date>2002-09-01</dc:date>
<dc:identifier>10.1177/107424840200700305</dc:identifier>
<dc:title><![CDATA[Comparison of Verapamil and Ibutilide for the Suppression of Immediate Recurrences of Atrial Fibrillation after Transthoracic Cardioversion]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://cpt.sagepub.com/cgi/content/short/7/1/9?rss=1&amp;ssource=mfc">
<title><![CDATA[Endothelin in Health and Disease: Endothelin Receptor Antagonists in the Management of Pulmonary Artery Hypertension]]></title>
<link>http://cpt.sagepub.com/cgi/content/short/7/1/9?rss=1&amp;ssource=mfc</link>
<description><![CDATA[Nick H.S. Kim, Lewis J. Rubin<br />Mar  1, 2002; 7:9-19<br />Article]]></description>
<dc:creator>Nick H.S. Kim, Lewis J. Rubin</dc:creator>
<dc:date>2002-03-01</dc:date>
<dc:identifier>10.1177/107424840200700i102</dc:identifier>
<dc:title><![CDATA[Endothelin in Health and Disease: Endothelin Receptor Antagonists in the Management of Pulmonary Artery Hypertension]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://cpt.sagepub.com/cgi/content/short/6/3/237?rss=1&amp;ssource=mfc">
<title><![CDATA[Electrophysiologic Effects of a Novel Selective Adenosine A1 Agonist (CVT-510) on Atrioventricular Nodal Conduction in Humans]]></title>
<link>http://cpt.sagepub.com/cgi/content/short/6/3/237?rss=1&amp;ssource=mfc</link>
<description><![CDATA[Bruce B. Lerman, Kenneth A. Ellenbogen, Alan Kadish, Edward Platia, Kenneth M. Stein, Steven M. Markowitz, Suneet Mittal, David J. Slotwiner, Marc Scheiner, Sei Iwai, Luiz Belardinelli, Markus Jerling, Revati Shreeniwas, Andrew A. Wolff<br />Sep  1, 2001; 6:237-245<br />Article]]></description>
<dc:creator>Bruce B. Lerman, Kenneth A. Ellenbogen, Alan Kadish, Edward Platia, Kenneth M. Stein, Steven M. Markowitz, Suneet Mittal, David J. Slotwiner, Marc Scheiner, Sei Iwai, Luiz Belardinelli, Markus Jerling, Revati Shreeniwas, Andrew A. Wolff</dc:creator>
<dc:date>2001-09-01</dc:date>
<dc:identifier>10.1177/107424840100600304</dc:identifier>
<dc:title><![CDATA[Electrophysiologic Effects of a Novel Selective Adenosine A1 Agonist (CVT-510) on Atrioventricular Nodal Conduction in Humans]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://cpt.sagepub.com/cgi/content/short/6/2/147?rss=1&amp;ssource=mfc">
<title><![CDATA[Renal Artery Stenosis in Minority Patients Undergoing Diagnostic Cardiac Catheterization: Prevalence and Risk Factors]]></title>
<link>http://cpt.sagepub.com/cgi/content/short/6/2/147?rss=1&amp;ssource=mfc</link>
<description><![CDATA[Imad A. Alhaddad, Steve Blum, Eliot N. Heller, Milton A. Beato, Narendra C. Bhalodkar, Ghassan E. Keriaky, Edward J. Brown Jr<br />Jun  1, 2001; 6:147-153<br />Article]]></description>
<dc:creator>Imad A. Alhaddad, Steve Blum, Eliot N. Heller, Milton A. Beato, Narendra C. Bhalodkar, Ghassan E. Keriaky, Edward J. Brown Jr</dc:creator>
<dc:date>2001-06-01</dc:date>
<dc:identifier>10.1177/107424840100600206</dc:identifier>
<dc:title><![CDATA[Renal Artery Stenosis in Minority Patients Undergoing Diagnostic Cardiac Catheterization: Prevalence and Risk Factors]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://cpt.sagepub.com/cgi/content/short/6/1/31?rss=1&amp;ssource=mfc">
<title><![CDATA[Fenoldopam Infusion Associated with Preserving Renal Function After Aortic Cross-Clamping for Aneurysm Repair]]></title>
<link>http://cpt.sagepub.com/cgi/content/short/6/1/31?rss=1&amp;ssource=mfc</link>
<description><![CDATA[Timothy B. Gilbert, Jawad U. Hasnain, William R. Flinn, Michael P. Lilly, Marshall E. Benjamin<br />Mar  1, 2001; 6:31-36<br />Article]]></description>
<dc:creator>Timothy B. Gilbert, Jawad U. Hasnain, William R. Flinn, Michael P. Lilly, Marshall E. Benjamin</dc:creator>
<dc:date>2001-03-01</dc:date>
<dc:identifier>10.1177/107424840100600104</dc:identifier>
<dc:title><![CDATA[Fenoldopam Infusion Associated with Preserving Renal Function After Aortic Cross-Clamping for Aneurysm Repair]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

<item rdf:about="http://cpt.sagepub.com/cgi/content/short/13/2/130?rss=1&amp;ssource=mfc">
<title><![CDATA[Physiologic Properties and Regulation of the Actin Cytoskeleton in Vascular Smooth Muscle]]></title>
<link>http://cpt.sagepub.com/cgi/content/short/13/2/130?rss=1&amp;ssource=mfc</link>
<description><![CDATA[Dale D. Tang, Yana Anfinogenova<br />Jun  1, 2008; 13:130-140<br />Article]]></description>
<dc:creator>Dale D. Tang, Yana Anfinogenova</dc:creator>
<dc:date>2008-06-01</dc:date>
<dc:title><![CDATA[Physiologic Properties and Regulation of the Actin Cytoskeleton in Vascular Smooth Muscle]]></dc:title>
<dc:publisher>SAGE Publications</dc:publisher>
</item>

</rdf:RDF>